Denis O, Tanghe A, Palfliet K, Jurion F, van den Berg T P, Vanonckelen A, Ooms J, Saman E, Ulmer J B, Content J, Huygen K
Department of Virology, Pasteur Institute of Brussels, Belgium.
Infect Immun. 1998 Apr;66(4):1527-33. doi: 10.1128/IAI.66.4.1527-1533.1998.
Vaccination of mice with plasmid DNA carrying the gene for the major secreted mycobacterial antigen 85A (Ag85A) from Mycobacterium tuberculosis is a powerful technique for generating robust specific Thl helper T-cell responses, CD8+-mediated cytotoxicity, and protection against M. tuberculosis challenge (K. Huygen et al., Nat. Med. 2:893-898, 1996). We have now analyzed in more detail the antigen-specific immune CD4+- and CD8+-T-cell responses induced in BALB/c mice vaccinated with Ag85A DNA and have compared these responses to those generated by intravenous infection with M. tuberculosis. T-cell-epitope mapping, as measured by interleukin-2 and gamma interferon secretion from splenic T cells restimulated in vitro with synthetic 20-mer peptides spanning the complete mature sequence of Ag85A, demonstrated that DNA vaccination stimulated a stronger and broader T-cell response than did M. tuberculosis infection. Moreover, elevated cytotoxic T lymphocyte (CTL) activity against Ag85A-transfected and peptide-pulsed P815 target cells could be generated exclusively by vaccination with plasmid DNA, not following M. tuberculosis infection. By using DNA vaccination, three Ag85A CTL epitopes with predicted major histocompatibility complex class I binding motifs were defined. One of them was previously reported as a dominant, promiscuously recognized T-cell epitope in healthy humans with primary infections. These data strengthen the potential of DNA vaccination with respect to inducing antituberculous immunity in humans.
用携带结核分枝杆菌主要分泌性分枝杆菌抗原85A(Ag85A)基因的质粒DNA对小鼠进行疫苗接种,是一种产生强大的特异性Th1辅助性T细胞应答、CD8⁺介导的细胞毒性以及抵抗结核分枝杆菌攻击的保护作用的有效技术(K. 于伊根等人,《自然医学》2:893 - 898,1996年)。我们现在更详细地分析了用Ag85A DNA接种的BALB/c小鼠中诱导的抗原特异性免疫CD4⁺和CD8⁺ T细胞应答,并将这些应答与静脉内感染结核分枝杆菌所产生的应答进行了比较。通过用跨越Ag85A完整成熟序列的合成20聚体肽在体外重新刺激脾T细胞后测量白细胞介素-2和γ干扰素分泌来进行T细胞表位定位,结果表明DNA疫苗接种比结核分枝杆菌感染刺激了更强、更广泛的T细胞应答。此外,针对Ag85A转染和肽脉冲处理的P815靶细胞的细胞毒性T淋巴细胞(CTL)活性升高仅可通过用质粒DNA进行疫苗接种产生,而不是在结核分枝杆菌感染后产生。通过使用DNA疫苗接种,确定了三个具有预测的主要组织相容性复合体I类结合基序的Ag85A CTL表位。其中一个先前被报道为在原发性感染的健康人类中占主导地位、被广泛识别的T细胞表位。这些数据增强了DNA疫苗接种在诱导人类抗结核免疫方面的潜力。